Clinical Trial Update: Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update on expanded cord blood use for patients requiring an allogeneic stem cell transplant has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Hematologic Malignancy | Phase 1, Phase 2 | Status: COMPLETED